Otsuka (OTCMKTS:OTSKY) Sees Strong Trading Volume – Still a Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) shares saw unusually-high trading volume on Wednesday . Approximately 107,123 shares were traded during mid-day trading, an increase of 180% from the previous session’s volume of 38,276 shares.The stock last traded at $37.95 and had previously closed at $38.16.

Otsuka Trading Down 1.0%

The firm’s fifty day simple moving average is $36.61 and its 200 day simple moving average is $35.06. The stock has a market capitalization of $40.57 billion, a P/E ratio of 15.17, a price-to-earnings-growth ratio of 2.76 and a beta of 0.02. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21.

Otsuka (OTCMKTS:OTSKY) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The business had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, equities research analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current fiscal year.

About Otsuka

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products holding company whose businesses focus on pharmaceuticals, nutraceuticals and other consumer health products. Through its operating companies, the group researches, develops, manufactures and markets prescription medicines for areas including psychiatry, oncology, cardiovascular disease and nephrology.

Otsuka’s consumer health portfolio includes products such as Pocari Sweat hydration beverages, Oronamin C nutritional drinks, CalorieMate balanced nutrition products and Nature Made dietary supplements.